These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23469999)

  • 1. Towards sustainability: new approaches to nano-drug preparation.
    Cheow WS; Xu R; Hadinoto K
    Curr Pharm Des; 2013; 19(35):6229-45. PubMed ID: 23469999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-sized crystalline drug production by milling technology.
    Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
    Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
    Ozeki T; Tagami T
    Curr Pharm Des; 2013; 19(35):6259-69. PubMed ID: 23470003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology versus other techniques in improving drug dissolution.
    Kwok PC; Chan HK
    Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Nanonisation Technologies: Tailoring Crystalline Versus Amorphous Nanomaterials.
    Serrano DR; Gallagher KH; Healy AM
    Curr Top Med Chem; 2015; 15(22):2327-40. PubMed ID: 26043733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
    Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
    Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and in vitro characterization of solid dosage form incorporating drug nanoparticles.
    Basa S; Muniyappan T; Karatgi P; Prabhu R; Pillai R
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1209-18. PubMed ID: 18720147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical Modifications and Nano Particulate Strategies for Improved Bioavailability of Poorly Water Soluble Drugs.
    Siddiqui K; Waris A; Akber H; Munir K; Mir M; Khan MW; Aman W; Fakhar-Ud-Din
    Pharm Nanotechnol; 2017; 5(4):276-284. PubMed ID: 29278217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y; Han X; Wang J; Wang Y
    Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of polymers enabling nano-comminution of water-insoluble drugs.
    Lee J; Choi JY; Park CH
    Int J Pharm; 2008 May; 355(1-2):328-36. PubMed ID: 18261866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocrystalization: An Emerging Technology to Enhance the Bioavailability of Poorly Soluble Drugs.
    Joshi K; Chandra A; Jain K; Talegaonkar S
    Pharm Nanotechnol; 2019; 7(4):259-278. PubMed ID: 30961518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
    Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical nanocrystals: production by wet milling and applications.
    Malamatari M; Taylor KMG; Malamataris S; Douroumis D; Kachrimanis K
    Drug Discov Today; 2018 Mar; 23(3):534-547. PubMed ID: 29326082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.